Kewei Xu

423 total citations
19 papers, 341 citations indexed

About

Kewei Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Kewei Xu has authored 19 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Kewei Xu's work include Cancer, Lipids, and Metabolism (2 papers), Receptor Mechanisms and Signaling (2 papers) and Cancer-related molecular mechanisms research (2 papers). Kewei Xu is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), Receptor Mechanisms and Signaling (2 papers) and Cancer-related molecular mechanisms research (2 papers). Kewei Xu collaborates with scholars based in China, Australia and Canada. Kewei Xu's co-authors include Rene E. Harrison, Zhi Ping Xu, Sujeeve Jeganathan, He Sun, Wenyi Gu, Yifan Liu, Tian Li, Helen J. Cooper, Zi Gu and Lei Yang and has published in prestigious journals such as Journal of Biological Chemistry, Chemistry - A European Journal and Frontiers in Pharmacology.

In The Last Decade

Kewei Xu

18 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kewei Xu China 7 115 73 67 53 34 19 341
Huiyang Wang China 9 116 1.0× 118 1.6× 24 0.4× 112 2.1× 47 1.4× 21 344
Miaojuan Qiu China 13 202 1.8× 30 0.4× 32 0.5× 73 1.4× 52 1.5× 21 425
Pengfei Yang China 14 172 1.5× 97 1.3× 126 1.9× 72 1.4× 29 0.9× 25 577
Yiming Liu China 12 121 1.1× 75 1.0× 142 2.1× 45 0.8× 14 0.4× 32 546
Zhirui Zhang China 11 138 1.2× 27 0.4× 26 0.4× 57 1.1× 53 1.6× 28 342
Xiaojun Cai China 13 146 1.3× 53 0.7× 40 0.6× 43 0.8× 8 0.2× 27 380

Countries citing papers authored by Kewei Xu

Since Specialization
Citations

This map shows the geographic impact of Kewei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Xu more than expected).

Fields of papers citing papers by Kewei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Xu. The network helps show where Kewei Xu may publish in the future.

Co-authorship network of co-authors of Kewei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Xu. A scholar is included among the top collaborators of Kewei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Xu. Kewei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hu, Jintao, Juanyi Shi, Shizhong Xu, et al.. (2025). A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5. Journal of Experimental & Clinical Cancer Research. 44(1). 218–218. 1 indexed citations
2.
3.
Zhou, Nan, et al.. (2025). An EcDNA gene-based risk model and functional verification of a key ec-lncRNA AC016394.2 for prostate cancer. Cancer Cell International. 25(1). 240–240. 1 indexed citations
4.
Xu, Kewei, et al.. (2024). Uncoupling Protein 2 Alleviates Myocardial Ischemia/Reperfusion Injury by Inhibiting Cardiomyocyte Ferroptosis. Journal of Vascular Research. 61(3). 109–121. 2 indexed citations
5.
Fan, Fan, et al.. (2022). Radiologically anatomic measurement analysis for the third sacral foramen and an efficient implantation protocol for sacral neuromodulation. Neurourology and Urodynamics. 41(5). 1149–1156. 1 indexed citations
6.
7.
Li, Kuiqing, et al.. (2022). WGCNA and molecular docking reveal key hub genes and potential natural inhibitor in interstitial cystitis/bladder pain syndrome. International Urogynecology Journal. 33(8). 2241–2249. 3 indexed citations
8.
Li, Kaiwen, Wenzeng Yang, Zhuohang Li, et al.. (2022). A Scoring System for Optimal Selection of Endoscopic Treatment for 1-2cm Lower Pole Renal Calculi.. PubMed. 19(5). 356–362. 6 indexed citations
9.
Shi, Juanyi, Ze Gao, Jiawen Luo, et al.. (2022). HMMR Promotes Prostate Cancer Proliferation and Metastasis via AURKA/mTORC2/E2F1 Positive Feedback Loop. SSRN Electronic Journal. 1 indexed citations
10.
Li, Jing, et al.. (2021). Gabapentin Reduces Alcohol Intake in Rats by Regulating NF-κB Signaling Pathway Via PPAR γ. Alcohol and Alcoholism. 57(2). 234–241. 2 indexed citations
11.
Yan, Shiyu, Kewei Xu, Li Li, et al.. (2018). The Pathways for Layered Double Hydroxide Nanoparticles to Enhance Antigen (Cross)-Presentation on Immune Cells as Adjuvants for Protein Vaccines. Frontiers in Pharmacology. 9. 1060–1060. 32 indexed citations
12.
Li, Tian, Kewei Xu, & Yifan Liu. (2018). Anticancer effect of salidroside reduces viability through autophagy/PI3K/Akt and MMP‑9 signaling pathways in human bladder cancer cells. Oncology Letters. 16(3). 3162–3168. 27 indexed citations
13.
Zuo, Huali, Weiyu Chen, Bei Li, et al.. (2017). MnAl Layered Double Hydroxide Nanoparticles as a Dual‐Functional Platform for Magnetic Resonance Imaging and siRNA Delivery. Chemistry - A European Journal. 23(57). 14299–14306. 56 indexed citations
14.
Li, Zhuohang, Cheng Liu, Kuiqing Li, et al.. (2016). Nox4 has a crucial role in uric acid-induced oxidative stress and apoptosis in renal tubular cells. Molecular Medicine Reports. 13(5). 4343–4348. 38 indexed citations
15.
Xu, Kewei & Rene E. Harrison. (2015). Down-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages. Journal of Biological Chemistry. 290(31). 19245–19260. 13 indexed citations
16.
Chen, Jiezhong, Wenyi Gu, Lei Yang, et al.. (2015). Nanotechnology in the management of cervical cancer. Reviews in Medical Virology. 25(S1). 72–83. 53 indexed citations
17.
Sun, He, et al.. (2012). Classically Activated Macrophages Use Stable Microtubules for Matrix Metalloproteinase-9 (MMP-9) Secretion. Journal of Biological Chemistry. 287(11). 8468–8483. 97 indexed citations
18.
Guo, Dagang & Kewei Xu. (2005). [Application of polyvinyl alcohol in biomedical engineering].. PubMed. 22(3). 602–5. 1 indexed citations
19.
Lin, Tianxin, Jian Huang, Hai Huang, et al.. (2005). [Identification of response element gene sequence for non-steroid hormone transcription factors for the activation and up-regulation of L-plastin expression in prostate cancer].. PubMed. 11(10). 731–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huiyang Wang Breakdown of academic impact, for papers by Miaojuan Qiu Breakdown of academic impact, for papers by Pengfei Yang Breakdown of academic impact, for papers by Yiming Liu Breakdown of academic impact, for papers by Zhirui Zhang Breakdown of academic impact, for papers by Xiaojun Cai
Rankless by CCL
2026